Parkinson's Disease Treatment - STALEVO
  Novartis Pharma US

 





Novartis invites you to visit our site devoted to senior health and Medicare Part D.  Click here.

optimizing levodopa delivery optimizing levodopa delivery doctor
New STALEVO enhances the benefits of levodopa therapy What is STALEVO?
Read reprints from published journal articles to learn more about the effects of STALEVO on motor fluctuations in patients.
 Find Out More


STALEVO is a combination of carbidopa, levodopa, and entacapone for the treatment of Parkinson's disease patients with end-of-dose wearing off. STALEVO may help your patients have better symptom control for longer periods of time between doses.
E-detail Product Information
Safety & Efficacy
Read information about the safety and efficacy of STALEVO
 Learn More



Resources for Patients
Information to help your patients better manage Parkinson's disease
 Find Resources

Please see Important Safety Information.




STALEVO Home  |  STALEVO Overview  |  More Information About PD
Resource Center  |  Important Safety Information
Prescribing Information

Site Guide  |  Contact Us

Novartis Pharma US Use of website is governed by the Terms of Use and Privacy Statement .
Copyright ©2008
Novartis Pharmaceuticals Corporation. All rights reserved.

Novartis proudly supports the Together Rx Access program.
Together Rx Access